Company: SFB
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-094691
Chunk: 40

Company: STIFEL FINANCIAL CORP
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 40
---
 Brown, 1,914; Ms. Carnoy, 1,914; Mr. Grady, 0; Mr. Kavanaugh, 1,914; Mr. Ludeman, 1,914; Ms. Markus, 1,914; Mr. Peacock, 1,914; Mr. Zimmerman, 1,914. |

| (2) | In addition to an annual cash retainer of $100,000 for serving as a director, the various committee chairs and the lead independent director were awarded additional cash retainers as follows: Lead Independent Director, $30,000; and Committee Chairs, $30,000. New directors who served partial years received a prorated quarterly amount. |

| (3) | In addition to an annual cash retainer of $100,000, each non-employee director was issued the equivalent of $150,000 in stock units on June 5, 2024. The units vest on a quarterly basis over a one-year period. Amounts stated reflect the aggregate grant date fair value computed in accordance with ASC 718. |

| (4) | Mr. Grady waived compensation to ensure compliance with policies of Summit Partners, an entity unaffiliated with the Company. Mr. Grady is an advisory partner of Summit Partners. |

Grants of RSUs to non-employeedirectors of the Company are generally granted annually and vest on a quarterly basis over a one-yearperiod. As approved by the Board, the annual stock retainer payable to each non-employeedirector includes an award of the equivalent of $150,000 in stock units and $100,000 cash. The chair of each standing committee and the Lead Independent Director each receive $30,000 in cash, for services in each such capacity. Each non-employeedirector also receives reimbursement of travel and similar expenses incurred to attend Board meetings. Directors who are also our employees do not receive any compensation for their service as directors of the Company or its subsidiaries, but we pay their expenses for attendance at meetings of the Board. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS The Sarbanes-Oxley Act of 2002 generally prohibits loans by an issuer and its subsidiaries to its executive officers and directors. However, the Sarbanes-Oxley Act contains a specific exemption from such prohibition for loans to its executive officers and directors in compliance with federal banking regulations. Federal regulations require that all loans or extensions of credit to executive officers and directors of insured financial institutions must